Shuttle Pharmaceuticals Holdings (SHPH) Common Equity (2021 - 2026)

Shuttle Pharmaceuticals Holdings' Common Equity history runs 6 years deep, the most recent figure standing at $3.3 million for Q1 2026.

• On a quarterly basis, Common Equity rose 1.86% year-over-year to $3.3 million in Q1 2026; TTM through Mar 2026 was $3.3 million, a 1.86% increase from a year earlier, with the FY2025 full-year figure at $2.3 million, up 217.91% from the prior year.
• Common Equity advanced to $3.3 million in Q1 2026 per SHPH's latest filing, from $2.3 million in the prior quarter.
• Across five years, Common Equity topped out at $8.4 million in Q3 2022 and bottomed at -$2.3 million in Q2 2022.
• The 5-year median for Common Equity is $3.3 million (2025), against an average of $3.1 million.
• Across the five-year window, Common Equity surged 535.2% in 2022 and tumbled 123.45% in 2024, its largest moves.
• Year by year, Common Equity stood at $7.7 million in 2022, then tumbled by 47.18% to $4.1 million in 2023, then sank by 82.51% to $709152.0 in 2024, then surged by 217.91% to $2.3 million in 2025, then jumped by 48.43% to $3.3 million in 2026.
• Per Business Quant, the three latest SHPH Common Equity figures stand at $3.3 million (Q1 2026), $2.3 million (Q4 2025), and $1.4 million (Q3 2025).